Author:
Krasnikova T. L.,Nikitin P. I.,Ksenevich T. I.,Gorshkov S. G.,Bushueva T. L.,Arefieva T. I.,Ruleva N. Yu.,Sidorova M. V.,Azmuko A. A.,Bespalova Zh. D.
Subject
Cell Biology,Biochemistry,Biophysics
Reference32 articles.
1. Rollins B.J. 1997. MCP-1, MCP-2, MCP-3, MCP-4, and MCP-5. Blood. 90, 909–928.
2. Krasnikova T.L., Arefieva T.I., Kukhtina N.B., 2003. Chemokines, chemokine receptors and atherogenesis. Uspekhi sovr. biologii (Rus.). 123, 506–514.
3. Deshmane S. L., Kremlev S., Amini S., Sawaya B.E. 2009. Monocyte chemoattractant protein-1 (MCP-1): An overview. J. Interferon Cytokine. 29(6), 313–326.
4. Reckless J., Tatalick L.M., Grainger D.J. 2001. The pan-chemokine inhibitor NR58-3.14.3 abolishes tumour necrosis factor-alpha accumulation and leucocyte recruitment induced by lipopolysaccharide in vivo. Immunology. 103, 2244–2254.
5. Lau E.K., Paavola C.D., Johnson Z., Gaudry J.P., Geretti E., Borlat F., Kungl A.J., Proudfoot A.E., Handel T.M. 2004. Identification of the glycosaminoglycan binding site of the CC chemokine, MCP-1: Implications for structure and function in vivo. J. Biol. Chem. 279(21), 22294–22305.